Miracor Medical Systems announced the first treatments of patients with the PiCSO Impulse System in the United Arab Emirates (UAE), marking the launch of this novel therapy in Asia in cooperation with Medical Technology.
The first cases using the PiCSOAMI Impulse System have been performed by Dr. Arif Al Nooryani, CEO and Head of Cardiac Center and his team at Al Qassimi Hospital, the largest public hospital in Sharjah emirate and largest hospital under the umbrella of the Federal Ministry of Health in the UAE.
"We applied PiCSO therapy during complex PCI procedures, treating non-ST-elevation myocardial infarction patients," said Dr. Arif Al Nooryani.
"Directly following diagnostic angiography, we initiated PiCSO therapy for the duration of the complex stenting procedures to improve myocardial perfusion. I was impressed to see the immediate effect of PiCSO, as my patients did not experience chest pain, nor did we see ECG changes or signs of no-reflow phenomena, which can normally be expected during such procedures," he continued.
The procedures in the UAE were performed with the support of Access Medical, a UAE-based medical devices distributor and sister company of Medical Technology Est., which is now co-operating with Miracor to launch the PiCSO Impulse System also in the Kingdom of Saudi Arabia, Kuwait and Oman.
"The launch of PiCSO in Asia marks an important milestone in the ongoing commercialization of PiCSO worldwide," says Lars Schiemanck, Managing Director of Miracor.
Miracor Medical Systems is an Austrian medical device company developing innovative solutions to treat severe heart diseases; striving to bring back cardiac patients to normal life.
Miracor develops and commercializes the PiCSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, a technology platform designed to improve clinical outcome of patients with impaired cardiac function.